Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location Prognostic p-value RNA cancer category RNA tissue category RNA TS RNA TS TPM TPM max in non-specific KCNMA1 KCa1.1, mSLO1, SLO ENSG00000156113 Potassium channel, calcium activated large conductance subfamily M alpha, member 1 10 76869601-77638595 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level HPA054648 Approved Mixed Tissue enhanced smooth muscle: 147.6 endometrium: 122.5 KCNN1 hSK1, KCa2.1 ENSG00000105642 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1 19 17951293-18000080 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level HPA065938 Approved Actin filaments
Cytosol Tissue enhanced Tissue enriched 10 cerebral cortex: 21.5 testis: 2.0 KCNN2 hSK2, KCa2.2 ENSG00000080709 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2 5 114360945-114496500 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level HPA038221 Uncertain Uncertain Nucleoplasm
Cytosol Group enriched Tissue enhanced adrenal gland: 27.4;prostate: 18.5 liver: 15.9 KCNN3 hSK3, KCa2.3, SKCA3 ENSG00000143603 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3 1 154697455-154870280 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level HPA017990, HPA057127 Uncertain Approved Nucleoplasm Renal cancer:1.97e-4 (unfavourable) Tissue enhanced Tissue enhanced cerebral cortex: 25.4 fallopian tube: 9.4 KCNN4 hIKCa1, hKCa4, hSK4, IK, KCa3.1 ENSG00000104783 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 19 43766533-43781257 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters, Voltage-gated ion channels Evidence at protein level HPA053841, HPA059622 Approved Renal cancer:1.05e-14 (unfavourable), Urothelial cancer:1.75e-4 (favourable), Glioma:3.77e-4 (unfavourable), Pancreatic cancer:4.56e-4 (unfavourable) Expressed in all Tissue enhanced salivary gland: 74.3 stomach: 37.1 KCNT1 KCa4.1, KIAA1422, SLACK, Slo2.2 ENSG00000107147 Potassium channel, sodium activated subfamily T, member 1 9 135702185-135795508 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level HPA059880 Uncertain Tissue enhanced Group enriched 5 cerebral cortex: 11.7;ovary: 3.9;skeletal muscle: 3.9;spleen: 6.7 testis: 1.2 KCNT2 KCa4.2, SLICK, SLO2.1 ENSG00000162687 Potassium channel, sodium activated subfamily T, member 2 1 196225779-196609225 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level HPA051218 Uncertain Approved Vesicles Renal cancer:1.67e-5 (unfavourable) Mixed Tissue enhanced ovary: 6.0 cerebral cortex: 3.5